Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997 [1]

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 1, 2007, Pages 116-

  Frieden, Thomas R ^a   Munsiff, Sonal S ^a   Ahuja, Shama Desai ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

CD4 LYMPHOCYTE COUNT; DRUG BLOOD LEVEL; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL RATE; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTITUBERCULAR; CAPREOMYCIN SULFATE; CLINICAL TRIALS; DRUG ADMINISTRATION ROUTES; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; NEW YORK CITY; RIFAMPIN; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 33846252290     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Caminero J A. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006; 10: 829-837.
2. Frieden T R, Sherman L F, Maw K L, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. JAMA 1996; 276: 1229-1235.
3. Munsiff S S, Ahuja S D, Li J, et al. Public-private collaboration for multidrug-resistant tuberculosis control in New York City. Int J Tuberc Lung Dis 2006; 10: 639-648.